NEW YORK (GenomeWeb) – Roche said today that sales for its Diagnostics division grew 7 percent in the first nine months of 2016, driven primarily by immunodiagnostic products.
In total, the Swiss pharmaceutical and diagnostics company booked CHF 37.51 billion ($38.03 billion) in sales for the first three quarters, a 6 percent increase over sales of CHF 35.53 billion during the same period in 2015. On a constant currency basis, sales grew 4 percent in the first nine months of 2016.